| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies | Company's Home Page |
| Careside, Inc. |
| 6100 Bristol Parkway, Culver City, CA 90230 * (310) 338-6767 |
| Business Description | The company is developing and commercializing a proprietary point-of-care blood testing system called the "Careside System". The Careside System provides cost-effective, accurate test results within 10 to 15 minutes at the point of care or near the patient for a broad menu of routine blood tests. |
| Offering Information Company has | |||
| Trading As | CSA (AMEX) | Industry | Manufacturing (SIC 3841) |
| Type of Stock Offered | Common Shares | Filing Date | 05/05/1999 |
| Domestic Shares Offered | 2,000,000 | Offer Date | 06/15/1999 |
| Foreign Shares Offered | 0 | Filing Price | $7.50 |
| Company Shares | 2,000,000 | Offer Price | $7.50 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $0.463 |
| Gross Proceeds | $15,000,000 | Selling | $0.300 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 5,084,340 | Employees | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Paulson Investment Company, Inc. | Lead Manager | (503) 243-6028 |
| Marion Bass Securities Corporation | Co-manager | (704) 519-4701 |
| Millennium Financial Group Inc. | Co-manager | (212) 459-3765 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 9 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/1994 | 12/31/1995 | 12/31/1996 | 12/31/1997 | 09/30/1997 | 09/30/1998 | |
| Revenues | - | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| Income from Oper. | - | -0.975 | -2.695 | -1.617 | -6.536 | -4.954 | -6.808 |
| Net Income | - | - | - | -1.638 | -6.331 | -4.781 | -6.612 |
| E.P.S | - | - | - | -2.250 | -2.040 | -1.590 | -1.480 |
| Revenue Growth (%) | - | - | - | - | - | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -6.50 | -4.86 | -6.00 | ||||
| Cash Flow - Inv. | -0.89 | -0.77 | -2.51 | ||||
| Cash Flow - Fin. | 8.60 | 8.60 | 10.10 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 09/30/1998 | Financial Ratios | ||||
| Total Assets | 3.14 | Current Assets | 5.37 | Current Ratio | 3.66 |
| Total Liab. | 0.70 | Current Liab. | 1.47 | Debt Ratio | 22.37% |
| Total Equity | 2.44 | Working Cap. | 3.91 | Debt to Equity Ratio | 0.29 |
| Cash | 1.24 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to complete product development, launch product development and related expenses, purchase manufacturing equipment and expansion of facilities, to build an inventory and provide working capital and to repay outstanding indebtedness and for general corporate purposes. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Pepper Hamilton & Scheetz |
| Bank's Law Firm | Mintz, Levin, Cohn, Ferris, Glovsky And Popeo |
| Registrar/Transfer Agent | American Stock Transfer & Trust Co |
| Auditor | Arthur Andersen |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Warrant Information | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||